News from endo international plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 10, 2019, 17:00 ET Endo to Announce First-Quarter 2019 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its first-quarter 2019 financial results on May 9, 2019 and members of its senior management team will host a conference call and webcast at 7:30 a....


Apr 05, 2019, 07:30 ET Endo Begins Shipment of Authorized Generic Version of PROVENTIL® (albuterol sulfate) HFA Inhalation Aerosol in the United States

Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized generic version of Merck's PROVENTIL® (albuterol...


Mar 27, 2019, 21:11 ET Endo International plc Announces Early Tender Results of its Previously Announced Cash Tender Offers and Consent Solicitations for up to $1.5 billion

Endo International plc (NASDAQ: ENDP) (the "Company" or "Endo") today announced the early tender results of the previously announced cash tender offers (the "Tender Offers") made by Endo Finance LLC...


Mar 19, 2019, 07:30 ET Endo Announces Publication Of Collagenase Clostridium Histolyticum (CCH) Phase 2 Data In Dermatologic Surgery

Endo International plc (NASDAQ: ENDP) today announced the publication of Phase 2 data evaluating collagenase clostridium histolyticum (or "CCH") for the treatment of cellulite in Dermatologic...


Mar 14, 2019, 20:06 ET Endo International plc Announces Pricing of Private Offering Of Senior Secured Notes

Endo International plc (NASDAQ: ENDP) ("Endo") today announced that Par Pharmaceutical, Inc. (the "Issuer"), its wholly-owned subsidiary, priced $1.5 billion aggregate principal amount of 7.500%...


Mar 14, 2019, 20:06 ET Endo International plc Announces an Upsizing of its Cash Tender Offers and Consent Solicitations

Endo International plc (NASDAQ: ENDP) today announced an upsizing of its previously announced cash tender offers (the "Tender Offers") and consent solicitations by Endo Finance LLC ("Endo Finance"),...


Mar 14, 2019, 07:54 ET Endo International plc Announces Debt Refinancing Transactions, Including Cash Tender Offers and Consent Solicitations for up to $1.0 billion

Endo International plc (NASDAQ: ENDP) today announced a series of debt refinancing transactions that are intended to help manage the debt maturity profile of it and certain of its subsidiaries...


Mar 14, 2019, 07:51 ET Endo International plc Announces Proposed Private Offering Of Senior Secured Notes

Endo International plc (NASDAQ: ENDP) ("Endo") today announced that Par Pharmaceutical, Inc. (the "Issuer"), its wholly-owned subsidiary, intends to offer senior secured notes, subject to market and...


Mar 04, 2019, 08:00 ET Endo to Participate at Cowen & Company 39th Annual Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Cowen & Company 39th Annual Healthcare Conference in Boston, Massachusetts...


Mar 01, 2019, 15:27 ET Endo Announces FDA Decision Not to Include Vasopressin on 503B Bulks List

Endo International plc ("Endo") (NASDAQ: ENDP) today announced that the U.S. Food and Drug Administration (FDA) has determined that there is no clinical need to compound vasopressin under Section...


Mar 01, 2019, 07:30 ET Endo Will Showcase Late-Breaking Phase 3 CCH Data at the 2019 American Academy of Dermatology Annual Meeting

Endo International plc (NASDAQ: ENDP) today announced that it will present new data showing collagenase clostridium histolyticum (CCH) significantly met the clinical endpoint of improved cellulite...


Feb 28, 2019, 06:30 ET Endo Reports Fourth-Quarter And Full Year 2018 Financial Results

Fourth-quarter 2018 revenues increased 2 percent to $786 million Fourth-quarter 2018 Sterile Injectables revenues increased 32 percent to $259 million Fourth-quarter 2018 XIAFLEX® franchise revenues...


Feb 27, 2019, 17:15 ET Endo Announces Termination of Acquisition Agreements with Somerset Therapeutics and Business of Affiliate Wintac Limited

Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries, Endo Ventures Limited, Par Pharmaceutical, Inc. and Par Formulations Private Limited, have terminated their respective...


Feb 22, 2019, 07:30 ET Paladin Labs Inc. Announces Approval of Envarsus PA™ (tacrolimus prolonged-release tablets) in Canada

Paladin Labs Inc. and Endo Ventures Limited, subsidiaries of Endo International plc (NASDAQ: ENDP), today announced Health Canada's approval of Envarsus PA™ (tacrolimus prolonged-release tablets) for ...


Feb 07, 2019, 08:00 ET Endo Agrees Not To Oppose Additional Stay of FDA Litigation Following Restoration of Government Appropriations

Endo International plc ("Endo") (NASDAQ: ENDP) today announced that the U.S. Food and Drug Administration (the "FDA") has requested a further stay of Endo's ongoing litigation against the FDA through ...


Jan 25, 2019, 17:22 ET Endo to Announce Fourth-Quarter and Full-Year 2018 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its fourth-quarter and full-year 2018 financial results on February 28, 2019 and members of its senior management team will host a conference call...


Dec 31, 2018, 07:30 ET Endo Announces Anticipated Further Stay of Compounding Litigation Due to Lapse of Government Appropriations

Endo International plc ("Endo"; NASDAQ: ENDP) today announced that, due to the ongoing federal government shutdown, the U.S. Food and Drug Administration (the "FDA") has requested a further stay of...


Dec 19, 2018, 07:30 ET Endo to Participate at J.P. Morgan Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan Healthcare Conference in San Francisco, California on Monday, January 7, 2019 at 11:30 ...


Nov 28, 2018, 16:34 ET Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Bank of America Merrill Lynch Leveraged Finance Conference in Boca Raton,...


Nov 26, 2018, 12:55 ET Endo to Participate at Piper Jaffray Global Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Piper Jaffray Global Healthcare Conference in New York City on Tuesday,...


Nov 08, 2018, 07:00 ET Endo Reports Third-Quarter 2018 Financial Results

Third-quarter 2018 revenues of $745 million compared to third-quarter 2017 revenues of $787 million Third-quarter 2018 XIAFLEX® franchise revenues increased 22 percent versus third-quarter 2017 to...


Nov 07, 2018, 07:30 ET Endo Announces Positive Results from Phase 3 Studies of Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite

Endo International plc (NASDAQ: ENDP) announced positive results today from two identical Phase 3 RELEASE* studies of collagenase clostridium histolyticum (CCH) for the treatment of cellulite in the...


Oct 11, 2018, 07:30 ET Endo Presents Data on the Perception and Measurement of Cellulite Severity at the American Society for Dermatologic Surgery (ASDS) Annual Meeting

Endo International plc (NASDAQ: ENDP) today announced that data regarding the evaluation and rating of cellulite severity will be presented at the Annual Meeting of the American Society for...


Sep 28, 2018, 08:30 ET Endo Pharmaceuticals Issues Voluntary Nationwide Recall for Two Lots of Robaxin® 750mg Tablets 100 Count Bottle Packs Due to Incorrect Daily Dosing

Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Endo Pharmaceuticals Inc., is voluntarily recalling two lots of Robaxin® (methocarbamol tablets, USP) 750mg...


Sep 24, 2018, 06:00 ET Endo Agrees to Additional Stay of FDA Litigation Following FDA's Commitment to Use Best Efforts to Finalize Vasopressin Clinical Need Determination

Endo International plc (NASDAQ: ENDP) today announced that it has agreed to an additional stay of its litigation against the U.S. Food and Drug Administration (FDA) until December 31, 2018. The...